Technical Analysis for XTLB - XTL Biopharmaceuticals Ltd.

Grade Last Price % Change Price Change
grade F 1.25 0.00% 0.00
XTLB closed unchanged on Thursday, June 4, 2020, on 1 percent of normal volume.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Up Down
Historical XTLB trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Calm After Storm Range Contraction 0.00%
Narrow Range Bar Range Contraction 0.00%
Fell Below 20 DMA Bearish 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Outside Day Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -4.58%

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

XTL Biopharmaceuticals Ltd., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of pharmaceutical products for the treatment of clinical unmet needs. It is focused on late stage clinical development of drugs for the treatment of multiple myeloma, schizophrenia, and hepatitis C. The company's lead drug candidate is recombinant human erythropoietin (rHuEPO) for the treatment of multiple myeloma blood cancer, as well as for the treatment of severe anemia. The rHuEPO has also granted an orphan drug designation from the FDA for the treatment of multiple myeloma blood cancer. The company is also developing SAM-101, a proprietary combination of antipsychotic drugs and a medicinal compound, which has completed Phase IIa clinical trials as a therapy for psychotic diseases, with focus on schizophrenia. The company was formerly known as Xenograft Technologies Ltd. and changed its name to XTL Biopharmaceuticals Ltd. in July 1995. XTL Biopharmaceuticals Ltd. was founded in 1993 and is headquartered in Herzliya, Israel.
Biotechnology Biopharmaceutical Life Sciences Pharmaceutical Industry Natural Sciences Medication Pharmacy Pharmaceutical Products Schizophrenia Multiple Myeloma FDA Hepatitis C

Is XTLB a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.75
52 Week Low 0.625
Average Volume 3,028
200-Day Moving Average 1.51
50-Day Moving Average 1.16
20-Day Moving Average 1.31
10-Day Moving Average 1.27
Average True Range 0.12
ADX 14.92
+DI 31.53
-DI 25.37
Chandelier Exit (Long, 3 ATRs ) 1.09
Chandelier Exit (Short, 3 ATRs ) 1.44
Upper Bollinger Band 1.49
Lower Bollinger Band 1.12
Percent B (%b) 0.34
BandWidth 28.23
MACD Line 0.02
MACD Signal Line 0.04
MACD Histogram -0.0149
Fundamentals Value
Market Cap 6.45 Million
Num Shares 5.16 Million
EPS -1.10
Price-to-Earnings (P/E) Ratio -1.14
Price-to-Sales 0.00
Price-to-Book 5.40
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.25
Resistance 3 (R3) 1.25 1.25 1.25
Resistance 2 (R2) 1.25 1.25 1.25 1.25
Resistance 1 (R1) 1.25 1.25 1.25 1.25 1.25
Pivot Point 1.25 1.25 1.25 1.25 1.25
Support 1 (S1) 1.25 1.25 1.25 1.25 1.25
Support 2 (S2) 1.25 1.25 1.25 1.25
Support 3 (S3) 1.25 1.25 1.25
Support 4 (S4) 1.25